Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 IL-6 and type 1 diabetes mellitus: T cell responses and increase in IL-6 receptor surface expression.

Literature DB >> 28164101

IL-6 and type 1 diabetes mellitus: T cell responses and increase in IL-6 receptor surface expression.

Karina Braga Gomes¹.

Abstract

Entities: Disease Gene

Year: 2017 PMID： 28164101 PMCID： PMC5253293 DOI： 10.21037/atm.2016.12.74

Source DB: PubMed Journal: Ann Transl Med ISSN： 2305-5839

× No keyword cloud information.

18 in total

1. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

Authors: Estelle Bettelli; Yijun Carrier; Wenda Gao; Thomas Korn; Terry B Strom; Mohamed Oukka; Howard L Weiner; Vijay K Kuchroo
Journal: Nature Date: 2006-04-30 Impact factor: 49.962

2. Hypoglycemic episodes are associated with inflammatory status in patients with type 1 diabetes mellitus.

Authors: Beata Kiec-Wilk; Bartlomiej Matejko; Urszula Razny; Magdalena Stankiewicz; Jan Skupien; Tomasz Klupa; Maciej T Malecki
Journal: Atherosclerosis Date: 2016-05-03 Impact factor: 5.162

3. Shedding of interleukin-6 receptor and tumor necrosis factor alpha. Contribution of the stalk sequence to the cleavage pattern of transmembrane proteins.

Authors: K Althoff; P Reddy; N Voltz; S Rose-John; J Müllberg
Journal: Eur J Biochem Date: 2000-05

4. Increased TLR2 expression in patients with type 1 diabetes: evidenced risk of microalbuminuria.

Authors: Marcela Abbott Galvão Ururahy; Melina Bezerra Loureiro; Francisco Paulo Freire-Neto; Karla Simone Costa de Souza; Irina Zuhl; José Brandão-Neto; Rosario Dominguez Crespo Hirata; Sonia de Quateli Doi; Ricardo Fernando Arrais; Mario Hiroyuki Hirata; Maria das Graças Almeida; Adriana Augusto de Rezende
Journal: Pediatr Diabetes Date: 2011-08-17 Impact factor: 4.866

5. Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression.

Authors: Christian Hundhausen; Alena Roth; Elizabeth Whalen; Janice Chen; Anya Schneider; S Alice Long; Shan Wei; Rebecca Rawlings; MacKenzie Kinsman; Stephen P Evanko; Thomas N Wight; Carla J Greenbaum; Karen Cerosaletti; Jane H Buckner
Journal: Sci Transl Med Date: 2016-09-14 Impact factor: 17.956

6. The lack of association between interleukin-6 gene -174 G/C polymorphism and the risk of type 1 diabetes mellitus: a meta-analysis of 18,152 subjects.

Authors: Yan-Wei Yin; Qian-Qian Sun; Bei-Bei Zhang; Ai-Min Hu; Qi Wang; Hong-Li Liu; Zhi-Zhen Hou; Yi-Hua Zeng; Rui-Jia Xu; Long-Bao Shi
Journal: Gene Date: 2012-12-13 Impact factor: 3.688

7. Association between type 1, type 2 cytokines, diabetic autoantibodies and 25-hydroxyvitamin D in children with type 1 diabetes.

Authors: I M Talaat; A Nasr; A A Alsulaimani; H Alghamdi; K A Alswat; D M Almalki; A Abushouk; A M Saleh; G Allam
Journal: J Endocrinol Invest Date: 2016-08-19 Impact factor: 4.256

8. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells.

Authors: Marc Veldhoen; Richard J Hocking; Christopher J Atkins; Richard M Locksley; Brigitta Stockinger
Journal: Immunity Date: 2006-02 Impact factor: 31.745

9. Increased Blood Levels of Growth Factors, Proinflammatory Cytokines, and Th17 Cytokines in Patients with Newly Diagnosed Type 1 Diabetes.

Authors: Kristi Alnek; Kalle Kisand; Kaire Heilman; Aleksandr Peet; Karin Varik; Raivo Uibo
Journal: PLoS One Date: 2015-12-04 Impact factor: 3.240

10. Association of Haemostatic and Inflammatory Biomarkers with Nephropathy in Type 1 Diabetes Mellitus.

Authors: Caroline Pereira Domingueti; Rodrigo Bastos Fóscolo; Janice Sepúlveda Reis; Fernanda Magalhães Freire Campos; Luci Maria S Dusse; Maria das Graças Carvalho; Karina Braga Gomes; Ana Paula Fernandes
Journal: J Diabetes Res Date: 2015-12-06 Impact factor: 4.011

5 in total

IL-6 and type 1 diabetes mellitus: T cell responses and increase in IL-6 receptor surface expression.

1. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

2. Hypoglycemic episodes are associated with inflammatory status in patients with type 1 diabetes mellitus.

3. Shedding of interleukin-6 receptor and tumor necrosis factor alpha. Contribution of the stalk sequence to the cleavage pattern of transmembrane proteins.

4. Increased TLR2 expression in patients with type 1 diabetes: evidenced risk of microalbuminuria.

5. Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression.

6. The lack of association between interleukin-6 gene -174 G/C polymorphism and the risk of type 1 diabetes mellitus: a meta-analysis of 18,152 subjects.

7. Association between type 1, type 2 cytokines, diabetic autoantibodies and 25-hydroxyvitamin D in children with type 1 diabetes.

8. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells.

9. Increased Blood Levels of Growth Factors, Proinflammatory Cytokines, and Th17 Cytokines in Patients with Newly Diagnosed Type 1 Diabetes.

10. Association of Haemostatic and Inflammatory Biomarkers with Nephropathy in Type 1 Diabetes Mellitus.

Review 1. Immune Mechanisms and Pathways Targeted in Type 1 Diabetes.

2. Proteins of TNF-α and IL6 Pathways Are Elevated in Serum of Type-1 Diabetes Patients with Microalbuminuria.

Review 3. Molecular biomarkers in diabetes mellitus (DM).

4. Inflammatory Consequences of Maternal Diabetes on the Offspring Brain: a Hippocampal Organotypic Culture Study.

Review 5. The Role and Impact of Extracellular Vesicles in the Modulation and Delivery of Cytokines during Autoimmunity.